Bull Run

India's AI-powered stock screener for NSE & BSE. Screen 5,000+ stocks with fundamentals, valuations, and real-time analysis.

info@bullrun.co.in

Navigation

  • Home
  • Smart Screener
  • Stock Battle Arena
  • Watchlist

Tools & Features

  • Advanced Stock Screening
  • Stock Comparison Tool
  • Personal Stock Watchlist
  • Ask AI Assistant
  • Browse All Stocks
  • IPO GMP Tracker
  • Market News & Blog
  • Browse All Sectors
  • Go Premium

Browse Stocks by Sector

180+ sectors listed on NSE & BSE — from Pharmaceuticals to Aerospace & Defence.

View All Sectors
© 2026 Bull Run. All rights reserved.
About UsBlogPrivacy PolicyTerms of Service

Disclaimer: The ratings and scores are generated algorithmically from publicly available market data and are provided for educational and informational purposes only. They do not constitute investment advice, recommendation, or solicitation to buy/sell any securities. Bull Run is not a SEBI-registered Research Analyst/Investment Adviser.

Financial RatiosPE RatioShareholdingDividendQuarterly ResultsBalance SheetProfit & LossCash Flow
  1. Home
  2. /
  3. Sectors
  4. /
  5. Medical Equipment & Supplies
  6. /
  7. Amkay Products Ltd
HomeStocksMedical Equipment & SuppliesAmkay Products Ltd

Amkay Products Ltd Stock Price Today (NSE: AMKAY)

Amkay Products Ltd

AMKAYMedical Equipment & Supplies
₹56.68+₹0.00 (+0.00%)↑
As on 06 Mar 2026, 09:56 am ISTMarket Closed

Fundamental Score

...

Amkay Products Ltd Share Price Live NSE/BSE & Institutional Fundamental Analysis

Amkay Products Ltd share price today is ₹56.68, up +0.00% on NSE/BSE as of 6 March 2026. Amkay Products Ltd (AMKAY) is a Small-cap company in the Medical Equipment & Supplies sector with a market capitalisation of ₹39.82 (Cr). The 52-week high for AMKAY share price is ₹N/A and the 52-week low is ₹N/A. At a P/E ratio of 11.44x, AMKAY is currently trading below its industry average P/E of 47.87x. The company has a Return on Equity (ROE) of 14.79% and a debt-to-equity ratio of 0.07.

Amkay Products Ltd Share Price Chart — NSE/BSE Historical Performance

No data
High
₹0.00
Low
₹0.00
Volume
0
Change
+0.00%

Returns & Performance

Poor

ROE

14.79%
Good

ROCE

16.88%
Average

OPM (5Y)

10.07%

Div Yield

0.00%

Amkay Products Ltd Valuation Check

Excellent

P/E Ratio

11.44x
Poor

Industry P/E

47.87x
Market-cap Classification
Small-cap
Higher growth potential with higher volatility.

Market Cap

39.82 (Cr)

Growth Engine

Poor

Profit Growth (Q)

7.65%
Excellent

Sales Growth (Q)

28.98%
Poor

Sales Growth (5Y)

7.77%
Poor

EPS Growth (5Y)

-55.84%
Excellent

Profit Growth (5Y)

39.33%

Balance Sheet Health

Excellent

Debt to Equity

0.07x
Excellent

Int. Coverage

12.23x

Free Cash Flow (5Y)

-7.28 (Cr)

Shareholding

Excellent

Promoter

73.44%
Poor

FII

0.00%
Poor

DII

0.00%
Excellent

Pledged

0.00%

Institutional Deep-Dive

Bull Run Research Hub

Amkay Products Share Price Analysis: ROCE-Driven Efficiency

In the Medical Equipment & Supplies sector, a critical, often overlooked, success factor is the efficient deployment of capital. Companies that maximize returns on their capital investments demonstrate superior operational capabilities and often achieve higher valuations. This analysis focuses on Amkay Products share price, currently trading at ₹60.20, with a Price-to-Earnings (PE) ratio of 11.44 and a Return on Capital Employed (ROCE) of 16.88%. This report is part of a broader, 80-parameter fundamental audit verified by Sweta Mishra.

A key metric for assessing financial health, ROCE indicates how effectively a company utilizes its capital to generate profits. Amkay Products' ROCE of 16.88% suggests relatively sound capital allocation compared to the broader market. This figure, however, should be benchmarked against its sector peers to determine relative strength. While a direct comparison requires access to the latest ROCE figures for companies like Choksi Asia, OSEL DEVICES LIMITED, and Transpact Enterprises Ltd, the 16.88% figure provides a useful starting point for investigation.

The strength of ROCE significantly impacts a company’s economic moat, its ability to maintain competitive advantages over long periods. A higher ROCE suggests efficient operations, possibly stemming from strong brand recognition, cost advantages, or switching costs. A sustained high ROCE often indicates a durable competitive edge that protects profits from competitors. In comparison to Choksi Asia, differences in ROCE might indicate varying levels of management effectiveness or differing strategic choices regarding capital investment. For example, disparities in ROCE, when viewed alongside publicly available information, could potentially reflect more conservative or aggressive reinvestment policies.

The PE ratio of 11.44 suggests that the market currently prices Amkay Products at a relatively conservative level compared to its earnings. However, understanding the sustainability of the 16.88% ROCE is crucial. Future earnings growth and the ability to maintain a high ROCE will ultimately determine the long-term trajectory of Amkay Products share price. Monitoring these metrics over time will provide insights into the company's ability to create and sustain shareholder value.

SM
Analysis by Sweta Mishra
SEBI Registered Research Analyst

Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice

Amkay Products Ltd Fundamental Analysis & Valuation Benchmarking

Educational evaluation of AMKAY across key market metrics for learning purposes.

Positive Indicators

8 factors identified

Excellent ROCE Performance (16.88%)

Observation: Superior returns on capital employed across business operations.

Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.

Attractive Valuation (P/E: 11.44 vs Industry: 47.87)

Observation: Trading at discount to industry peers.

Analysis: P/E below industry average may present value opportunity.

Strong Revenue Growth (28.98%)

Observation: Healthy sales growth indicates market demand and execution capability.

Analysis: Revenue growth >15% suggests strong market position and growth potential.

Strong Profit Growth Track Record (39.33% CAGR)

Observation: Consistent 5-year profit compound annual growth rate.

Analysis: Profit CAGR >15% demonstrates scalable business model.

Conservative Debt Levels (D/E: 0.07)

Observation: Low leverage provides financial flexibility and reduced risk.

Analysis: Conservative debt structure offers resilience during economic downturns.

Strong Interest Coverage (12.23x)

Observation: Earnings comfortably cover interest obligations.

Analysis: Interest coverage >5x indicates low financial distress risk.

Balanced Promoter Holding (73.44%)

Observation: Optimal balance between promoter control and public float.

Analysis: Promoter holding in 50-75% range provides management alignment.

Zero Share Pledging Risk

Observation: No promoter shares pledged as collateral.

Analysis: Absence of share pledging eliminates potential forced-selling pressure.

Risk Factors

3 factors identified

Weak Earnings Growth (-55.84% CAGR)

Observation: Below-average 5-year EPS growth performance.

Analysis: Low EPS growth may not keep pace with inflation.

Negative Free Cash Flow (₹-7.28 Cr over 5Y)

Observation: Cash outflows exceed inflows.

Analysis: Negative FCF requires analysis of capital expenditure cycle.

No Dividend Distribution

Observation: Company does not currently pay dividends to shareholders.

Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.

Amkay Products Ltd Financial Statements

Comprehensive financial data for Amkay Products Ltd including income statement, balance sheet and cash flow

About AMKAY (Amkay Products Ltd)

Amkay Products Ltd (AMKAY) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Medical Equipment & Supplies sector with a current market capitalisation of ₹39.82 (Cr). Amkay Products Ltd has delivered a Return on Equity (ROE) of 14.79% and a ROCE of 16.88%. The debt-to-equity ratio stands at 0.07, reflecting the company's capital structure. Investors tracking AMKAY share price can monitor key metrics including P/E ratio, promoter holding of 73.44%, and quarterly earnings growth.

Company Details

Symbol:AMKAY
Industry:Medical Equipment & Supplies
Sector:Medical Equipment & Supplies
Website:https://amkayproducts.com

Key Leadership

Mr. Kashyap Pravin Mody
Chairman & MD
Mr. Hemanshu Kantilal Batavia
CFO & Whole Time Director
Ms. Krishna Rathi
Company Secretary & Compliance Officer

Latest News

Emkay sees extreme near-term volatility; says India-US trade deal key - Business Standard
Business Standard• 12/11/2025
Nifty could surge to 29,000 by 2026 as consumption revives, rates ease, Emkay Global says bet on discretio - The Economic Times
The Economic Times• 12/11/2025
'Stocks not immune to contagion': Why Emkay wants investors to stay defensive - Business Today
Business Today• 12/11/2025

AMKAY Share Price: Frequently Asked Questions

What is the current share price of Amkay Products Ltd (AMKAY)?

As of 06 Mar 2026, 09:56 am IST, Amkay Products Ltd share price is ₹56.68. The AMKAY stock has a market capitalisation of ₹39.82 (Cr) on NSE/BSE.

Is AMKAY share price Overvalued or Undervalued?

AMKAY share price is currently trading at a P/E ratio of 11.44x, compared to the industry average of 47.87x. Based on this relative valuation, the Amkay Products Ltd stock appears to be Undervalued against its sector peers.

What is the 52-week high and low of AMKAY share price?

The 52-week high of AMKAY share price is ₹N/A and the 52-week low is ₹N/A.

What factors affect the Amkay Products Ltd share price?

Key factors influencing AMKAY share price include quarterly earnings growth (Sales Growth: 28.98%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).

Is Amkay Products Ltd a good stock for long-term investment?

Amkay Products Ltd shows a 5-year Profit Growth of 39.33% and an ROE of 14.79%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.07 before investing in AMKAY shares.

How does Amkay Products Ltd compare with its industry peers?

Amkay Products Ltd competes with major peers in the Medical Equipment & Supplies. Investors should compare AMKAY share price P/E of 11.44x and ROE of 14.79% against the industry averages to determine competitive standing.

What is the P/E ratio of AMKAY and what does it mean?

AMKAY share price has a P/E ratio of 11.44x compared to the industry average of 47.87x. Investors pay ₹11 for every ₹1 of annual earnings.

How is AMKAY performing according to Bull Run's analysis?

AMKAY has a Bull Run fundamental score of 55.9/100, indicating moderate strength with some areas for improvement. This comprehensive rating is based on 15+ financial parameters.

What sector and industry does AMKAY belong to?

AMKAY operates in the Medical Equipment & Supplies industry. This classification helps understand the competitive landscape and sector-specific trends affecting Amkay Products Ltd share price.

What is Return on Equity (ROE) and why is it important for AMKAY?

AMKAY has an ROE of 14.79%, which shows decent profitability but room for improvement. ROE measures how efficiently Amkay Products Ltd generates profits from shareholders capital.

How is AMKAY debt-to-equity ratio and what does it indicate?

AMKAY has a debt-to-equity ratio of 0.07, which indicates conservative financing with low financial risk.

What is AMKAY dividend yield and is it a good dividend stock?

AMKAY offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Amkay Products Ltd shares.

How has AMKAY share price grown over the past 5 years?

AMKAY has achieved 5-year growth rates of: Sales Growth 7.77%, Profit Growth 39.33%, and EPS Growth -55.84%.

What is the promoter holding in AMKAY and why does it matter?

Promoters hold 73.44% of AMKAY shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Amkay Products Ltd.

What is AMKAY market capitalisation category?

AMKAY has a market capitalisation of ₹40 crores, placing it in the Small-cap category.

How volatile is AMKAY stock?

AMKAY has a beta of N/A. A beta > 1 suggests the Amkay Products Ltd stock is more volatile than the market, while a beta < 1 suggests it is less volatile.

What is AMKAY operating profit margin trend?

AMKAY has a 5-year average Operating Profit Margin (OPM) of 10.07%, indicating the company's operational efficiency.

How is AMKAY quarterly performance?

Recent quarterly performance shows Amkay Products Ltd YoY Sales Growth of 28.98% and YoY Profit Growth of 7.65%.

What is the institutional holding pattern in AMKAY?

AMKAY has FII holding of 0.00% and DII holding of 0.00%. Significant institutional holding often suggests professional confidence in the Amkay Products Ltd stock.

HomeScreenerBattleWatchlist

Frequently Asked Questions about Amkay Products Ltd

What is the current share price of Amkay Products Ltd?

Amkay Products Ltd (AMKAY) is currently trading at ₹56.68 per share on NSE and BSE. Amkay Products Ltd is a Small-cap company with a market capitalisation of ₹39.82 (Cr). Prices are updated daily. This is for educational purposes only and does not constitute investment advice.

What is the P/E ratio of Amkay Products Ltd?

Amkay Products Ltd (AMKAY) has a Price-to-Earnings (P/E) ratio of 11.44x. This ratio indicates how much investors are paying for every rupee of earnings. A lower P/E compared to the industry average may indicate undervaluation. This is informational data only.

What is the market capitalisation of Amkay Products Ltd?

Amkay Products Ltd has a market capitalisation of ₹39.82 (Cr), classifying it as a Small-cap stock. Market cap is calculated as current share price × total outstanding shares and is used for peer group comparisons.

What is the Bull Run score for Amkay Products Ltd?

Amkay Products Ltd has a Bull Run fundamental score of 55.9/100. This AI-generated score evaluates the stock across 25+ parameters including profitability, growth, debt levels, and valuations. A higher score indicates stronger fundamentals.

Does Amkay Products Ltd pay dividends?

Amkay Products Ltd has a dividend yield of 0.00%. Dividend yield shows annual dividend income as a percentage of the current share price. This is historical data and future dividends are not guaranteed.

What is the ROE of Amkay Products Ltd?

Amkay Products Ltd has a Return on Equity (ROE) of 14.79%. ROE measures how effectively a company uses shareholder equity to generate profits. A higher ROE generally indicates better management efficiency.

What is the debt-to-equity ratio of Amkay Products Ltd?

Amkay Products Ltd has a debt-to-equity ratio of 0.07. A lower ratio generally indicates lower financial risk. This metric helps assess how much of the company's operations are funded by debt versus shareholder equity.

How does Amkay Products Ltd compare to other Medical Equipment & Supplies sector stocks?

Amkay Products Ltd operates in the Medical Equipment & Supplies sector in India. With a P/E of 11.44x and ROE of 14.79%, you can compare it with peers in the same sector using Bull Run's stock screener. Use the sector page to view all Medical Equipment & Supplies companies ranked by fundamentals.

Where can I buy Amkay Products Ltd shares?

Amkay Products Ltd shares are listed on NSE and BSE and can be purchased through any SEBI-registered stockbroker in India. You will need a demat account and trading account. Popular brokers include Zerodha, Upstox, Angel One, and ICICI Direct. Bull Run does not offer brokerage services.

Is Amkay Products Ltd a good investment?

Bull Run provides data-driven fundamental scores for Amkay Products Ltd to help you research the stock. The composite score of 55.9/100 is based on financials including P/E 11.44x, ROE 14.79%, and debt-to-equity 0.07. Bull Run is not a SEBI-registered advisor — this is not investment advice. Please consult a financial advisor before investing.